Involvement of the PLCε/PKCα pathway in human BIU-87 bladder cancer cell proliferation

Cell Biology International

Volumn 35, Issue 10, 2011, Pages 1031-1036

  Ling, Yan ^a   Chunli, Luo ^a   Xiaohou, Wu ^b   Qiaoling, Zhang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Phospholipase Ce; Proliferation; Protein kinase Ca; Small hairpin RNA (shRNA)

Indexed keywords

PHOSPHOLIPASE C; PHOSPHOLIPASE C ALPHA; PHOSPHOLIPASE C EPSILON; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN BIU 87; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE; GENE SILENCING; HUMAN; HUMAN CELL; ONCOGENE C FOS; ONCOGENE C JUN; PLC EPSILON GENE;

CELL LINE, TUMOR; CELL PROLIFERATION; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; PHOSPHOINOSITIDE PHOSPHOLIPASE C; PROTEIN KINASE C-ALPHA; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPHINGOSINE; URINARY BLADDER NEOPLASMS;

EID: 80054975061     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090101     Document Type: Article

References (25)

1. Aaltonen V, Koivunen J, Laato M, Peltonen J. Heterogeneity of cellular proliferation within transitional cell carcinoma: correlation of protein kinase C alpha/betaI expression and activity. J. Histochem. Cytochem. 2006;54:795-806.
2. Ayan S, Gokce G, Kilicarslan H, Ozdemir O, Yildiz E, Gultekin EY. K-RAS mutation in transitional cell carcinoma of urinary bladder. Int. Urol. Nephrol. 2001;33:363-7.
3. Bai Y, Edamatsu H, Maeda S, Saito H, Suzuki N, Satoh T, Kataoka T. Crucial role of phospholipase Ce in chemical carcinogen-induced skin tumor development. Cancer Res. 2004;64:8808-10.
4. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-21.
5. Benimetskaya L, Miller P, Benimetsky S, Maciaszek A, Guga P, Beaucage SL, Wilk A, Grajkowski A, Halperin AL, Stein CA. Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-alpha (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides: relationship to the decreased viability of T24 bladder and PC3 prostate cancer cells. Mol. Pharmacol. 2001;60:1296-307.
6. 2++ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J. Biol. Chem. 2006;281:14026-40.
7. Buyru N, Tigli H, Ozcan F, Dalay N. Ras oncogene mutations in urine sediments of patients with bladder cancer. J. Biochem. Mol. Biol. 2003;36:399-402.
8. Cai Q, Li J, Gao T, Xie J, Evers BM. Protein kinase Cdelta negatively regulates hedgehog signaling by inhibition of Gli1 activity. J. Biol. Chem. 2009;284:2150-8.
9. Cao W, Li F, Steinberg RH, LaVail MM. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells. Invest. Ophthalmol. Vis. Sci. 1998;139:565-73.
10. Guo YC, Luo CL, Cai XZ, Wu XH, Pu J. Expression and clinical significance of phospholipase C-epsilon gene in transitional cell carcinoma of bladder. Chin. J. Clin. Lab. Sci. 2008;26:52-4.
11. Haughian, James M, Bradford, Andrew P. Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells. J. Cell Physiol. 2009;220:112-8.
12. Jiang, XH, Tu, SP, Cui, JT, Lin, MC, Xia, HH, Wong, WM, Chan, AO, Yun, MF, Jiang, SH, Lam, SK, et al. Antisense targeting protein kinase C alpha and beta1 inhibits gastric carcinogenesis. Cancer Res. 2004;64:5787-94.
13. Koivunen J, Aaltonen V, Peltonen J. Protein kinase C (PKC) family in cancer progression. Cancer Lett. 2005;235:1-10.
14. Kong C, Zhu Y, Liu D, Yu M, Li S, Li Z, Sun Z, Liu G. Role of protein kinase C-alpha in superficial bladder carcinoma recurrence. Urology 2004;65:1228-32.
15. Langzam L, Koren R, Gal R, Kugel V, Paz A, Farkas A, Sampson SR. Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy. Am. J.Clin. Pathol. 2001;16:377-85.
16. Li J, Yao S, Zhang Y. The role of c-Jun in the Ap-1 activation induced by naturally occurring isothiocyanates. Food Chem. Toxicol. 2005;43:1373-80.
17. Mackall J, Michael MM, Daniel L. A mild procedure for the rapid release of cytoplasmic enzymes from ultured animal cells. Anal. Biochem.1979;5:270-4.
18. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:1501-12.
19. Singal T, Dhalla NS, Tappia PS. Regulation of c-Fos and c-Jun gene expression by phospholipase C activity in adult cardiomyocytes. Mol. Cell. Biochem. 2009;327:229-239.
20. Smith SC, Oxford G, Baras AS, Owens C, Havaleshko D, Brautigan DL, Safo MK, Theodorescu D. Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clin. Cancer Res. 2007;13:3803-13.
21. Soh JW, Weinstein IB. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J. Biol. Chem. 2003;278:34709-16.
22. Suh HW, Choi SS, Lee JK, Lee HK, Han EJ, Lee J. Regulation of c-fos and c-jun gene expression by lipopolysaccharide and cytokines in primary cultured astrocytes: effect of PKA and PKC pathways. Arch. Pharm. Res. 2004;27:396-401.
23. Varga A, Czifra G, Tállai B, Németh T, Kovács I, Kovács L, Bíró T. Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas. Eur. Urol. 2004;46:462-5.
24. Wing MR, Bourdon DM, Harden TK. PLC-epsilon: a shared effector protein in Ras-, Rho-, and G alpha beta gamma-mediated signaling. Mol. Interv. 2003;3:273-80.
25. Yun SU, Hong WP, Choi JH, Yi KY, Cha SK, Ryu SH, Suh PG. Phospholipase C-e augments epidermal growth factor-dependent cell growth by inhibiting epidermal growth factor receptor downregulation. J. Biol. Chem. 2008;283:341-9.